Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
ACS Omega|September 13, 2022
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2023
Preventing occludin tight-junction disruption via inhibition of microRNA-193b-5p attenuates viral load and influenza-induced lung injuryChirag M Vaswani, Amir K Varkouhi, Sahil Gupta, et al.
The Journal of Infectious Diseases|February 10, 2023
CASP4/11 Contributes to NLRP3 Activation and COVID-19 ExacerbationTamara S Rodrigues, Camila C S Caetano, Keyla S G de Sá, et al.
Science Advances|September 14, 2022
Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infectionLetícia de Almeida, Alexandre L N da Silva, Tamara S Rodrigues, et al.
Blood|August 18, 2021
Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formationCamila Meirelles S Silva, Carlos Wagner S Wanderley, Flavio P Veras, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection of human lymphomononuclear cells by SARS-CoV-2Marjorie C Pontelli, Italo A Castro, Ronaldo B Martins, et al.
The Journal of Clinical Investigation|April 27, 2023
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular trapsBruna M Silva, Giovanni F Gomes, Flavio P Veras, et al.
Journal of Molecular Cell Biology|April 22, 2022
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patientsMarjorie C Pontelli, Ítalo A Castro, Ronaldo B Martins, et al.
The Journal of Experimental Medicine|November 24, 2020
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patientsTamara S Rodrigues, Keyla S G de Sá, Adriene Y Ishimoto, et al.
Pageof 3